Study of Varencline Effects on Cigarette Smoking Reward and Craving During a Model of Brief Quit Attempt

Withdrawn before enrolling · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Nicotine Dependence

In brief

Study of varenicline 2.0 mg/day treatment for 2 weeks with smoking test done in laboratory on Day 8 and a 1 week quit attempt from Day 8-14.

Key facts

Study ID

NCT00571805

Run by

NYU Langone Health

People needed

0

Starts

2007-09-01

Last updated by the study team

2015-04-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• At least 10 cigarettes/day
• Interest in quitting smoking
• Willgness to comply with overnight smoking abbstiennce period followed by lab smoking test

You may not qualify if…

• Pregnancy
• Axis I psychiatric disorder which require treatment with psychoactive medication and would make study compliance difficult.
• Clinically significant medical condition in opinion of study clinician
• Drug or alcohol dependence inlast 12 months
• Use of other smoking cessation medications ot treatment progams in last 2 months

Where it is running

• VA New York Harbor Healthcare System, MHAD clinic — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.